Previously, it has been determined that sarcopenia and associated pathologies present a chronic inflammatory response characterized by abnormal cytokine production (tumor necrosis alfa (TNF-α), interleukins 6 (IL-6) and 1 (IL-1)), increased acute phase reactants (C-reactive protein (CRP)), and trigger inflammatory signaling pathways, most commonly the NF-κB, MAPK, and JAK-STAT pathways [10]. This evidence concerns the gene IL6 and sarcopenia.